Recent Posts



  • Insmed stock at $100/$150 isn't too high for an acquisition. Celgene was $102 when it was acquired. Biogen was over $190. And any offer must be presented to the Board regardless.

anonymous
Jun 18, 2025 at 03:20 PM
  • “Racine-Kenosha is loaded with eager depressed lonely HCPs to dump “it” in.”

    sales leader

anonymous
Jun 18, 2025 at 03:17 PM
  • HUGE access wins being announced today, which should be a time to celebrate for everyone! Unfortunitely what you won’t hear today, which has already been decided is that based off these wins Q3 will be the largest growth goal percentages since launch. Now you might be asking how is that possible when they baked those expected wins into our Q1 & Q2 goals, which didn’t come to fruition or the fact that Q3 is historically the lowest volume quarter in the antidepressant category, well the answer is simply they don’t give a f-ck about you! You thought “summer is coming” was about getting as many new writers and new patients on board before the summer low, nope! Summer is coming was to warn you to start working out your butt hole because you are about to get f-cked! Remember access doesn’t sell the product, but it does allow us to gaslight you into thinking you can grow another 25% in Q3 over the 40% you’ve already grown this year. All IN or else! So don’t even think about complaining, all feedback should sound like, yes sir may I have another.
    Yup summer is cumming right in our a—-! Hard & dry, so grab your ankles and repeat after me, yes sir may I have another!

anonymous
Jun 18, 2025 at 03:06 PM
anonymous
Jun 18, 2025 at 03:05 PM
  • Dumpster Fire

anonymous
Jun 18, 2025 at 02:53 PM